Serum cystatin C and beta2-microglobulin as markers of glomerular filtration rate.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 12617340)

Published in Ren Fail on January 01, 2003

Authors

Dijana Jovanović1, Pavle Krstivojević, Ivana Obradović, Vesna Durdević, Ljubica Dukanović

Author Affiliations

1: Clinic of Nephrology, Clinical Center, Belgrade, Yugoslavia. jivana@EUnet.yu

Articles citing this

Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children. Crit Care (2007) 1.28

Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population. Clin J Am Soc Nephrol (2013) 1.11

Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese. PLoS One (2011) 1.05

A biomarker panel for peripheral arterial disease. Vasc Med (2008) 1.01

Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration. Haematologica (2009) 0.92

Early detection of acute kidney injury by serum cystatin C in critically ill children. Pediatr Nephrol (2013) 0.87

The influence of percutaneous nephrolithotomy on human systemic stress response, SIRS and renal function. Urol Res (2010) 0.83

Role of β2-microglobulin in uremic patients may be greater than originally suspected. World J Nephrol (2015) 0.79

Current Trends of Renal Impairment in Multiple Myeloma. Kidney Dis (Basel) (2016) 0.77

Comparison of serum beta 2-microglobulin and 24 hour urinary creatinine clearance as a prognostic factor in multiple myeloma. J Korean Med Sci (2006) 0.77

β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease. J Am Heart Assoc (2014) 0.77

A Study on the Relationship between Serum Beta 2-Microglobulin Levels, Underlying Chronic Kidney Disease, and Peripheral Arterial Disease in High-Vascular-Risk Patients. Int Cardiovasc Res J (2012) 0.76

High levels of serum β2-microglobulin predict severity of coronary artery disease. BMC Cardiovasc Disord (2017) 0.75

High Serum Level of β2-Microglobulin in Late Posttransplant Period Predicts Subsequent Decline in Kidney Allograft Function: A Preliminary Study. Dis Markers (2015) 0.75

Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease. Atherosclerosis (2017) 0.75

Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases. Front Med (Lausanne) (2017) 0.75